Pharmaceutical company Gufic Biosciences Limited announced the re-appointment of Dr. Rabi N. Sahoo as Independent Director on the company’s Board, with effect from June 29, 2022.
According to the company’s exchange filing, “this is to inform you that based on recommendation of Nomination & Remuneration Committee and subject to approval of members at the ensuing Annual General Meeting, the Board of Directors (“Board”) of the Company on June 28, 2022 vide resolution by circulation, have approved re-appointment of Dr. Rabi Sahoo (DIN: 01237464) as an Independent Director of the Company, whose current term expires on June 28, 2022, for the second term of two years commencing from June 29, 2022 to June 28, 2024.”
Dr. Rabi Sahoo has done graduation in MD,· pharmacology from AIIMS, New Delhi. In the year 1989, Dr. Sahoo joined Cadila Laboratories as medical advisor. He then moved to Torrent Pharmaceuticals in 1993 and later in 1995, he joined Sun Pharma Industries Limited (SPIL) as a General Manager and he was in charge of regulatory affairs, clinical research and medical services. He left SPIL in the year 2002 to pursue his interest as Senior Consultant in pharma industry. He has been associated with Centaur pharmaceuticals Pvt. Ltd. and many reputed companies in the past.
HrNxt.com Newsdesk has researchers and writers with an excellent domain knowledge about the talent ecosystem, and the business environment. The team keeps a tab on the latest happenings in the ecosystem to bring most relevant news and insights for our readers. You can connect with our newsdesk at newsdesk@hrnxt.com.